Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02483728
Other study ID # WUH 14318
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date August 2014
Est. completion date June 5, 2018

Study information

Verified date January 2020
Source NYU Langone Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate if metal patch testing in metal allergic patients is useful for predicting the development of allergic skin disease or systemic symptoms in patients who recieve a metal orthopedic implant.


Description:

This prospective cohort study will enroll patients with a history of metal allergy who require implantation of a metal orthopedic device. Patients will be followed for one year after surgery to determine if any symptoms including rash, itch, joint pain, joint swelling, and/or joint failure develop post implantation.

Patients will be recruited from two sites: (1) Divisions of Orthopedics and Allergy & Immunology, Winthrop University Hospital, and (2) Division of Immunology, and Allergy Section, University of Cincinnati Medical Center.


Recruitment information / eligibility

Status Terminated
Enrollment 6
Est. completion date June 5, 2018
Est. primary completion date June 5, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria

1. Age =18 years with a history of metal allergy who require joint repair (hip, knee and/or shoulder)

2. Able to undergo patch testing

Exclusion Criteria

1. Patients on oral immunosuppressant medications within 4 weeks of patch testing or topical corticosteroids to the back within 1 week of patch testing

2. Patients who are pregnant or breastfeeding

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Patch Test
Patch testing is a technique used to diagnose an allergic skin disease called allergic contact dermatitis. It attempts to reproduce in small scale allergic reactions of the skin from things that come in contact with it.This is the standard of care to determine allergic contact dermatitis.

Locations

Country Name City State
United States University of Cincinnati College of Medicine Cincinnati Ohio
United States Winthrop University Hospital Mineola New York

Sponsors (2)

Lead Sponsor Collaborator
NYU Langone Health Smart Practice

Country where clinical trial is conducted

United States, 

References & Publications (1)

Pinson ML, Coop CA, Webb CN. Metal hypersensitivity in total joint arthroplasty. Ann Allergy Asthma Immunol. 2014 Aug;113(2):131-6. doi: 10.1016/j.anai.2014.05.012. Epub 2014 Jun 13. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The development of rash assessed via a patient and physician questionnaire asking to answer yes or no to the following questions: Do you have new onset of itchy rash above the implant site? Do you have new onset of generalized itchy rash? Type of rash that has developed: eczema above implant, generalized eczema, urticaria, vasculitis Change from baseline physical exam prior to surgery (development of rash) at 4-6 weeks post date of surgery, 3 months post surgery, 6 months post surgery and one year post surgery.
Primary The development of joint pain or joint swelling assessed via a patient and physician questionnaire asking to answer yes or no to the following questions: Do you have pain at the site of your implant? Does the patient have atypical joint swelling? Change from baseline physical exam prior to surgery at 4-6 weeks post date of surgery, 3 months post surgery, 6 months post surgery and one year post surgery.
See also
  Status Clinical Trial Phase
Completed NCT00141180 - CP-481,715 Nickel Allergy Study. Phase 1
Completed NCT01953380 - Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy N/A
Completed NCT00928447 - Study of the Intradermal Injection of rHuPH20 or Placebo in Participants With Nickel Allergic Contact Dermatitis Phase 2
Completed NCT04182425 - Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk for Dysbiosis
Completed NCT03522675 - NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test N/A